Mo Yang

Identification of Novel Molecular Markers for Prognosis Estimation of Acute Myeloid Leukemia: Over-Expression of PDCD7, FIS1 and Ang2 May Indicate Poor Prognosis in Pretreatment Patients with Acute Myeloid Leukemia

Jinming Li, Zoufang Huang, Kai-kai Huang, 2014, PloS one.

Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-κB pathways.

F. Meng, Jie-yu Ye, Xuejie Jiang, 2012, Cancer letters.

The Impact of Ponatinib Versus Allogeneic Stem Cell Transplant (SCT) on Outcomes in Patients with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) with the T315I Mutation

H. Kantarjian, G. Martinelli, J. Cortes, 2015 .

Imatinib and bortezomib induce the expression and distribution of anaphase-promoting complex adaptor protein Cdh1 in blast crisis of chronic myeloid leukemia.

Kai-kai Huang, Xuejie Jiang, C. Yin, 2011, International journal of oncology.

[Molecular mechanism of imatinib-induced thrombocytopenia in treatment of patients with CML].

F. Meng, Ling-ling Shu, Qian-li Jiang, 2011, Zhongguo shi yan xue ye xue za zhi.

Clinical characteristics of acute lymphoblastic leukemia in male and female patients: A retrospective analysis of 705 patients.

F. Meng, Jie-yu Ye, Chunfu Li, 2015, Oncology letters.